Aileron Therapeutics Inc (ALRN)

Feb 05, 2025

Theratechnologies (NASDAQ:THTX) vs. Aileron Therapeutics (NASDAQ:ALRN) Head to Head Survey - Defense World

Feb 05, 2025

Feb 04, 2025

Aileron Therapeutics Reports Q3 2024 Financial Results - MSN

Feb 04, 2025

Jan 22, 2025

Aileron Therapeutics, Inc. announced that it has received $42 million in funding from a group of investors. - Marketscreener.com

Jan 22, 2025

Jan 16, 2025

Aileron straps in for 2025 with a new name: Rein Therapeutics - FiercePharma

Jan 16, 2025

Jan 14, 2025

Aileron Therapeutics and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma - Marketscreener.com

Jan 14, 2025

Jan 13, 2025

Aileron Therapeutics, Inc. Announces Board Changes - Marketscreener.com

Jan 13, 2025

Jan 13, 2025

Aileron Therapeutics, Inc. Announces Board Changes -April 01, 2019 at 06:16 am EDT - Marketscreener.com

Jan 13, 2025

Jan 13, 2025

Aileron Therapeutics to be Included in the Russell Microcap® Index - Marketscreener.com

Jan 13, 2025

Jan 13, 2025

Aileron Therapeutics Announces Appointments to Scientific Advisory Board -March 28, 2018 at 07:00 am EDT - Marketscreener.com

Jan 13, 2025

Jan 13, 2025

Aileron Therapeutics Announces the Promotion of Richard J. Wanstall to Chief Financial Officer and Treasurer - Marketscreener.com

Jan 13, 2025

Jan 13, 2025

Aileron Therapeutics Announces Board Appointments - Marketscreener.com

Jan 13, 2025

Jan 13, 2025

Aileron Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference - Marketscreener.com

Jan 13, 2025

Jan 13, 2025

Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights - Marketscreener.com

Jan 13, 2025

Jan 13, 2025

Aileron Therapeutics, Inc. Announces Management Changes - Marketscreener.com

Jan 13, 2025

Jan 13, 2025

Aileron Therapeutics Announces Management Changes - Marketscreener.com

Jan 13, 2025

Jan 13, 2025

Aileron Therapeutics, Inc. Announces CEO Changes - Marketscreener.com

Jan 13, 2025

Jan 13, 2025

Aileron Therapeutics Announces Management Changes -September 06, 2018 at 09:10 am EDT - Marketscreener.com

Jan 13, 2025

Jan 13, 2025

Rein Therapeutics announces name change and new ticker By Investing.com - Investing.com Canada

Jan 13, 2025

Jan 13, 2025

Rein Therapeutics announces name change and new ticker - Investing.com

Jan 13, 2025

Jan 11, 2025

Aileron Therapeutics announces rebranding to Rein Therapeutics - MSN

Jan 11, 2025

Jan 11, 2025

Geode Capital Management LLC Grows Position in Aileron Therapeutics, Inc. (NASDAQ:ALRN) - Defense World

Jan 11, 2025

Jan 11, 2025

Geode Capital Management LLC Boosts Stock Position in Pro-Dex, Inc. (NASDAQ:PDEX) - Defense World

Jan 11, 2025

Jan 10, 2025

Aileron Therapeutics Announces Rebranding to Rein Therapeutics - PR Newswire

Jan 10, 2025

Jan 10, 2025

RNTXRein Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Jan 10, 2025

Dec 12, 2024

Aileron Therapeutics to Present at the 8th Annual IPF Summit - The Eastern Progress Online

Dec 12, 2024

Dec 10, 2024

Aileron Therapeutics CEO James Brian Windsor buys $897 in stock By Investing.com - Investing.com Nigeria

Dec 10, 2024

Dec 09, 2024

Aileron Therapeutics CEO James Brian Windsor buys $897 in stock - Investing.com

Dec 09, 2024

Dec 06, 2024

Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) - The Eastern Progress Online

Dec 06, 2024

Nov 30, 2024

Aileron Therapeutics, Inc. (NASDAQ:ALRN) Sees Significant Decrease in Short Interest - MarketBeat

Nov 30, 2024

Nov 22, 2024

Chemotherapy Induced Anemia Treatment Market 2032: Clinical Trials, Medication, Prevalence, Incidence, Therapies, EMA, PDMA, FDA Approvals, and Companies by DelveInsight - Barchart

Nov 22, 2024

Nov 19, 2024

Aileron Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Citizentribune

Nov 19, 2024

Nov 17, 2024

Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Down 8.7% in October - MarketBeat

Nov 17, 2024

Nov 15, 2024

Aileron Therapeutics Inc (ALRN) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 14, 2024

Aileron Reports Positive Phase 1b Data for IPF Drug, Shows Strong Biomarker Response | ALRN Stock News - StockTitan

Nov 14, 2024

Nov 14, 2024

Pre-market Movers: ELAB, PHGE, CLDI, BJDX... - RTTNews

Nov 14, 2024

Nov 13, 2024

Aileron Therapeutics' Investigational Drug Shows Encouraging Action In Lung Fibrosis - AOL

Nov 13, 2024

Nov 13, 2024

Aileron reports promising phase 1b trial results for IPF treatment - Investing.com

Nov 13, 2024

Nov 13, 2024

Aileron reports promising phase 1b trial results for IPF treatment By Investing.com - Investing.com UK

Nov 13, 2024

Nov 13, 2024

Aileron Therapeutics Announces Positive Topline Data from Cohort 2 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) - Nasdaq

Nov 13, 2024

Nov 01, 2024

Advancium explores ALRN-6924 for pediatric eye cancer treatment - Investing.com India

Nov 01, 2024

Nov 01, 2024

Advancium explores ALRN-6924 for pediatric eye cancer treatment By Investing.com - Investing.com Canada

Nov 01, 2024

Oct 29, 2024

Short Interest in Aileron Therapeutics, Inc. (NASDAQ:ALRN) Drops By 14.2% - MarketBeat

Oct 29, 2024

Oct 28, 2024

Constrained Peptide Drugs Market Size, Scope and Share Analysis - InsightAce Analytic

Oct 28, 2024

Oct 14, 2024

Short Interest in Aileron Therapeutics, Inc. (NASDAQ:ALRN) Increases By 15.8% - MarketBeat

Oct 14, 2024

Oct 13, 2024

ALRNAileron Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Oct 13, 2024

Oct 12, 2024

Aileron Therapeutics to Present Previously Announced Data from the Phase 1b Clinical Trial Evaluating Low-Dose LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) at the 22nd International Colloquium on Lung and Airway Fibrosis - Lelezard

Oct 12, 2024

Oct 02, 2024

University of Texas Texas AM Investment Management Co. Invests $4.93 Million in Aileron Therapeutics, Inc. (NASDAQ:ALRN) - MarketBeat

Oct 02, 2024

Oct 01, 2024

Nantahala Capital Management LLC Raises Holdings in Aileron Therapeutics, Inc. (NASDAQ:ALRN) - MarketBeat

Oct 01, 2024

Sep 28, 2024

Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Down 13.4% in September - MarketBeat

Sep 28, 2024